Research ArticlesInvestigation of Transport Mechanism of Pentazocine across the Blood‐Brain Barrier Using the In Situ Rat Brain Perfusion Technique
Section snippets
INTRODUCTION
Pentazocine (PTZ), a relatively short‐acting narcotic‐antagonist analgesic, is used clinically for the relief of cancer‐related or postoperative pain because it is a reasonably potent analgesic with lower abuse liability than morphine.1., 2. The analgesic effects of PTZ are caused by interactions with specific opioid receptors in the brain.2 In agreement with the rapid onset of action observed clinically,3 PTZ readily penetrates the blood‐brain barrier (BBB) and immediately reaches the brain in
Radiochemicals and Chemicals
[Ring‐1, 3‐3H]‐(+)‐pentazocine ([3H]PTZ, specific activity 1417.1 GBq (38.3 Ci)/mmol), [carboxyl‐14C]‐inulin‐carboxyl (specific activity 0.071 GBq (1.92 mCi)/g), [methyl‐3H]‐diazepam ([3H]DZP, specific activity 3071 GBq (83.0 Ci)/mmol), and [3H]‐3‐O‐methyl‐D‐glucose ([3H]3OMG, specific activity 2782.4GBq (75.2 Ci)/mmol) were purchased from New England Nuclear Co. (Boston, MA). The radiochemical purity of the [3H]PTZ used for the experiment was greater than 99%. PTZ (Sosegon® injection) was
Concentration Dependence of PTZ Uptake by the Brain
The mean Fpf and Vv through the perfused left hemisphere in separate groups of animals were calculated as 39.2 ± 2.3 μL/s/g brain and 12.8 ± 1.4 μL/g brain, respectively. These values were in good agreement with the reported Fpf and Vv at a perfusion rate of 63 μL/s.16 In preliminary experiments, we examined the period over [3H]PTZ (0.02 μM) uptake to establish the best conditions for unidirectional influx measurements. The PSinf at 35 s was not significantly different from the value determined
DISCUSSION
We first attempted to determine whether the mechanism of BBB permeability to PTZ is either passive diffusion or carrier‐mediated transport using an in situ rat brain perfusion technique.14., 17. The decrease in PSinf with increasing PTZ concentration indicates the participation of a saturable uptake process (Table 1). The analysis of uptake kinetics provided one saturable component with a Km value of 2.9 mM, Vmax value of 27.2 nmol/s/g brain, and Kd value of 1.5 μL/s/g brain. The ratio of Vmax/K
CONCLUSION
The uptake kinetics of PTZ into the rat brain suggests parallel transport by a saturable, carrier‐mediated mechanism, and a nonsaturable system of passive diffusion. BBB transport of PTZ is mediated primarily by a carrier‐mediated system, rather than by simple diffusion. The inhibition of PTZ transport by some drugs suggests that it shares a common transport system with other cationic drugs; however, it differs from the choline carrier‐mediated system. Co‐perfusion of verapamil increased BBB
Acknowledgements
This work was supported in part by the Simabara Science Promotion Foundation for 2000, by a Research Grant for Assistants provided by Nihon University Research Grant for 2000, Japan, and by a Grant‐in‐Aid for Scientific Research (No. 13672328) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
REFERENCES (40)
- et al.
The uptake of pentazocine into brain
Life Sci
(1971) Pentazocine in rhesus monkey plasma and brain after parenteral and oral administration
Life Sci
(1973)- et al.
Drug delivery through the blood‐brain barrier
Adv Drug Delivery Rev
(1996) - et al.
Transporter‐mediated permeation of drugs across the blood‐brain barrier
J Pharm Sci
(2000) - et al.
P‐glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
Life Sci
(1992) - et al.
Blood‐brain barrier function of P‐glycoprotein
Adv Drug Delivery Rev
(1997) - et al.
Synthetic and natural opiates interact with P‐glycoprotein in multidrug‐resistant cells
J Biol Chem
(1993) - et al.
P‐glycoprotein‐mediated transport of morphine in brain capillary endothelial cells
Biochem Pharmacol
(1999) - et al.
Effects of short‐ and long‐term administration of pentazocine in man
Clin Pharmacol Ther
(1970) - et al.
Pentazocine: A review of its pharmacological properties, therapeutic efficacy and dependence liability
Drugs
(1973)
Relationship of pentazocine plasma levels to pharmacological activity in man
Clin Pharmacol Ther
Studies on absorption, biotransformation, and excretion of drug. VI. The fate of pentazocine in the rat
Oyo Yakuri
Serum and brain concentrations of pentazocine in relation to analgesic activity in mice
J Pharm Pharmacol
Physiological pharmacokinetic model for pentazocine. I. Tissue distribution and elimination in the rat
Int J Pharm
Pharmacokinetics of pentazocine and its occupancy of opioid receptors in rat brain
Biol Pharm Bull
Differential effects of buprenorphine and pentazocine on the regional cerebral metabolic rate for glucose in the conscious rat
Biol Pharm Bull
Relationships in the structure‐tissue distribution of basic drugs in the rabbit
Pharm Res
An in situ brain perfusion technique to study cerebrovascular transport in the rat
Am J Physiol
Estimation of the kinetic parameters of unidirectional transport across the blood‐brain barrier
J Neurochem
Pantothenic acid transport through the blood‐brain barrier
J Neurochem
Cited by (19)
Impact of capillary flow hydrodynamics on carrier-mediated transport of opioid derivatives at the blood-brain barrier, based on pH-dependent Michaelis-Menten and Crone-Renkin analyses
2017, European Journal of Pharmaceutical SciencesCitation Excerpt :Pentazocine is a lipophilic (log P 3.31, Yokogawa et al., 1990) narcotic-antagonist (potent non-addictive analgesic). Two types of rat data are available: (a) carotid injection brain uptake index, BUI (Suzuki et al., 2002a), and (b) ISBP (Suzuki et al., 2002b). The opioid is taken up into the brain by an influx transporter mechanism, which can be inhibited by pyrilamine and naloxone (Suzuki et al., 2002a, 2002b).
Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux
2010, Journal of Pharmaceutical SciencesCitation Excerpt :Recently, an unidentified organic cation-sensitive transporter, which is an energy-dependent, proton-coupled antiporter, was characterized by in vivo and in vitro observations for the BBB influx transport of oxycodone.35 Concerning mixed opioid agonist/antagonists, we also reported that the active influx transport of pentazocine across the BBB was mediated predominantly by the organic cation-sensitive transport system, rather than its passive diffusion.36 Therefore, we speculate that the high brain uptake of naloxone in the brain may be explained by the influx transport system(s) across the BBB.
Drug discovery interface lonization-specifie prediction of blood-brain permeability
2009, Journal of Pharmaceutical SciencesUnderstanding the Blood-Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics
2022, Clinical Pharmacology and TherapeuticsNovel methods for intranasal administration under inhalation anesthesia to evaluate nose-to-brain drug delivery
2018, Journal of Visualized Experiments